ALG 126081
Alternative Names: ALG-126081Latest Information Update: 03 Jun 2025
At a glance
- Originator Aligos Therapeutics
- Class Antivirals; Small interfering RNA
- Mechanism of Action Hepatitis B surface antigen expression inhibitors; RNA interference
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Hepatitis B